0001562180-21-001149.txt : 20210212 0001562180-21-001149.hdr.sgml : 20210212 20210212215112 ACCESSION NUMBER: 0001562180-21-001149 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREGORY JULIA P CENTRAL INDEX KEY: 0001226675 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 21631635 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 5 1 primarydocument.xml PRIMARY DOCUMENT X0306 5 2020-12-31 false 0 1 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001226675 GREGORY JULIA P C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 true false false false Common Shares 2020-07-01 4 M false L 18000.00 28.76 A 18000.00 D Common Shares 2020-07-01 4 S false L 14400.00 71.2001 D 3600.00 D Common Shares 2020-07-01 4 S false L 3600.00 72.559 D 0.00 D Stock Option (Right to Buy) 28.76 2020-07-01 4 M false L 18000.00 0.00 D 2019-05-01 2028-04-30 Common Shares 18000.00 0.00 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.73 - $71.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.1996 - $72.9850, inclusive. /s/ Jim Engelhart, Attorney-in-Fact 2021-02-12